Diamyd Medical strengthens its position in the manufacturing of biological medicines – positive feedback from the Swedish Medical Products Agency

Diamyd Medical today announces a significant advancement in the company’s operations related to the manufacturing of biological medicines (biologics). The company has successfully established manufacturing capacity in accordance with current quality requirements and regulatory guidelines, representing an important step in its continued development. The company has also received positive feedback from the Swedish Medical Products Agency regarding a previously conducted inspection. As a result, Diamyd Medical expects to obtain manufacturing authorization and a GMP (Good Manufacturing